Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M.
Nihon Jinzo Gakkai Shi 27(11): 1571-1583
1985
ISSN/ISBN: 0385-2385 PMID: 3007820 Document Number: 244445
Document emailed within 1 workday
Related Documents
Rasmussen, S.; Ibsen, H.; Giese, J. 1984: Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension Scandinavian Journal of Urology and Nephrology. Supplementum 79: 49-52Graziano, M.J.; Dethloff, L.A.; Griffin, H.E.; Pegg, D.G. 1993: Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats Archives Internationales de Pharmacodynamie et de Therapie 324: 87-104
Tajima, J.; Abe, K.; Yasujima, M.; Tanno, M.; Yoshinaga, K. 1984: Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(6): 779-789
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Svarstad, E.; Hultstrøm, D.; Jensen, D.; Jenssen, G.; Gravendeel, J.; Iversen, B.M. 2001: Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(15): 1784-1788
Abe, Y.; Sakamoto, W.; Fukui, K.; Iwao, H.; Takada, T.; Yamamoto, K. 1988: Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats Archives Internationales de Pharmacodynamie et de Therapie 292: 237-247
Abe, Y.; Miura, K.; Imanishi, M.; Yukimura, T.; Komori, T.; Okahara, T.; Yamamoto, K. 1980: Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs Journal of Pharmacology and Experimental Therapeutics 214(1): 166-170
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Ramirez, A.J.; Migliorini, M.; Gilbert, B.H.; Marco, E.J.; Sanchez, R.A. 1991: Non-modulating essential hypertension: renal hemodynamic effects of long-term angiotensin converting enzyme inhibition Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 9(6): S396-S397
Zeravica, R.; Stosić, Z.; Ilincić, B.; Crnobrnja, V.; Jakovljević, A.; Mijović, R. 2014: The effect of angiotensin converting enzyme inhibition on effective renal plasma flow in patients with diffuse renal parenchymal diseases and hypertension Medicinski Pregled 67(3-4): 78-82
Levenson, D.J.; Dzau, V.J. 1987: Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis Kidney International. Supplement 20: S173-S179
Karlberg, B.E.; Fyhrquist, F.; Grönhagen-Riska, C.; Tikkanen, I.; Ohman, K.P. 1984: Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report Scandinavian Journal of Urology and Nephrology. Supplementum 79: 103-106
Waeber, B.; Burnier, M.; Nussberger, J.; Brunner, H.R. 1987: Renal function after administration of angiotensin-converting enzyme inhibitors Schweizerische Medizinische Wochenschrift 117(37): 1359-1362
Pavliukova, E.N.; Bakhmet'eva, T.A.; Puzyrev, K.V.; Karpov, R.S. 2006: Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril Kardiologiia 46(9): 19-25
Britov, A.N.; Alamdarova, I.I.; Deev, A.D.; Orlov, A.A. 2003: Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension Kardiologiia 43(10): 66-71
Levine, T.B. 1989: Effect of angiotensin converting enzyme inhibition on renal function in the treatment of heart failure Clinical Therapeutics 11(4): 495-502
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Nakayama, M.; Tanno, Y.; Otsuka, Y.; Takahashi, H.; Ikeda, M.; Katoh, N.; Yokoyama, K.; Yamamoto, H.; Tokutome, G.; Hosoya, T. 2002: Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level Nihon Jinzo Gakkai Shi 44(7): 530-536
Almazov, V.A.; Ametov, A.S.; Shliakhto, E.V.; Dolgova, I.B.; Pushkarev, A.A. 1989: Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme Terapevticheskii Arkhiv 61(8): 13-15
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210